India is yet to discuss the price of the Pfizer / BioNTech vaccine and the company’s ability to deliver the orders placed by the country, even as the Central Standard Drug Control Organization or CDSCO reviews the emergency authorization requested by the developer of the vaccine. A senior government official …
Read More »Price and capacity, key areas as Pfizer applies for license in India
